# Bosentan in Myocardium Metabolism and Perfusion Measured by 18F-FDG and 82Rb PET/CT on PAH and CTEPH

> **NCT02970851** · — · TERMINATED · sponsor: **University of Lausanne Hospitals** · enrollment: 2 (actual)

## Conditions studied

- Myocardial Dysfunction
- Endothelial Dysfunction

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02970851
- **Lead sponsor:** University of Lausanne Hospitals
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2013-04
- **Primary completion:** 2018-12-31
- **Final completion:** 2018-12-31
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Slow patient recruitment after arrival of macitentan on the market
- **Last updated:** 2020-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02970851

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02970851, "Bosentan in Myocardium Metabolism and Perfusion Measured by 18F-FDG and 82Rb PET/CT on PAH and CTEPH". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02970851. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*